Discovery - University of Dundee - Online Publications

Library & Learning Centre

Ultraviolet A1 phototherapy

Standard

Ultraviolet A1 phototherapy : a British Photodermatology Group workshop report. / Kerr, A. C.; Ferguson, J.; Attili, S. K.; Beattie, P. E.; Coleman, A. J.; Dawe, R. S.; Eberlein, B.; Goulden, V.; Ibbotson, S. H.; Menage, H. du P.; Moseley, H.; Novakovic, L.; Walker, S. L.; Woods, J. A.; Young, A. R.; Sarkany, R. P. E.

In: Clinical and Experimental Dermatology, Vol. 37, No. 3, 2012, p. 219-226.

Research output: Contribution to journalArticle

Harvard

Kerr, AC, Ferguson, J, Attili, SK, Beattie, PE, Coleman, AJ, Dawe, RS, Eberlein, B, Goulden, V, Ibbotson, SH, Menage, HDP, Moseley, H, Novakovic, L, Walker, SL, Woods, JA, Young, AR & Sarkany, RPE 2012, 'Ultraviolet A1 phototherapy: a British Photodermatology Group workshop report' Clinical and Experimental Dermatology, vol 37, no. 3, pp. 219-226.

APA

Kerr, A. C., Ferguson, J., Attili, S. K., Beattie, P. E., Coleman, A. J., Dawe, R. S., Eberlein, B., Goulden, V., Ibbotson, S. H., Menage, H. D. P., Moseley, H., Novakovic, L., Walker, S. L., Woods, J. A., Young, A. R., & Sarkany, R. P. E. (2012). Ultraviolet A1 phototherapy: a British Photodermatology Group workshop report. Clinical and Experimental Dermatology, 37(3), 219-226doi: 10.1111/j.1365-2230.2011.04256.x

Vancouver

Kerr AC, Ferguson J, Attili SK, Beattie PE, Coleman AJ, Dawe RS et al. Ultraviolet A1 phototherapy: a British Photodermatology Group workshop report. Clinical and Experimental Dermatology. 2012;37(3):219-226.

Author

Kerr, A. C.; Ferguson, J.; Attili, S. K.; Beattie, P. E.; Coleman, A. J.; Dawe, R. S.; Eberlein, B.; Goulden, V.; Ibbotson, S. H.; Menage, H. du P.; Moseley, H.; Novakovic, L.; Walker, S. L.; Woods, J. A.; Young, A. R.; Sarkany, R. P. E. / Ultraviolet A1 phototherapy : a British Photodermatology Group workshop report.

In: Clinical and Experimental Dermatology, Vol. 37, No. 3, 2012, p. 219-226.

Research output: Contribution to journalArticle

Bibtex - Download

@article{9223ec506618490c9f77f9f5e9c01613,
title = "Ultraviolet A1 phototherapy",
author = "Kerr, {A. C.} and J. Ferguson and Attili, {S. K.} and Beattie, {P. E.} and Coleman, {A. J.} and Dawe, {R. S.} and B. Eberlein and V. Goulden and Ibbotson, {S. H.} and Menage, {H. du P.} and H. Moseley and L. Novakovic and Walker, {S. L.} and Woods, {J. A.} and Young, {A. R.} and Sarkany, {R. P. E.}",
note = "© The Author(s). CED © 2012 British Association of Dermatologists.",
year = "2012",
volume = "37",
number = "3",
pages = "219--226",
journal = "Clinical and Experimental Dermatology",
issn = "0307-6938",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Ultraviolet A1 phototherapy

T2 - a British Photodermatology Group workshop report

A1 - Kerr,A. C.

A1 - Ferguson,J.

A1 - Attili,S. K.

A1 - Beattie,P. E.

A1 - Coleman,A. J.

A1 - Dawe,R. S.

A1 - Eberlein,B.

A1 - Goulden,V.

A1 - Ibbotson,S. H.

A1 - Menage,H. du P.

A1 - Moseley,H.

A1 - Novakovic,L.

A1 - Walker,S. L.

A1 - Woods,J. A.

A1 - Young,A. R.

A1 - Sarkany,R. P. E.

AU - Kerr,A. C.

AU - Ferguson,J.

AU - Attili,S. K.

AU - Beattie,P. E.

AU - Coleman,A. J.

AU - Dawe,R. S.

AU - Eberlein,B.

AU - Goulden,V.

AU - Ibbotson,S. H.

AU - Menage,H. du P.

AU - Moseley,H.

AU - Novakovic,L.

AU - Walker,S. L.

AU - Woods,J. A.

AU - Young,A. R.

AU - Sarkany,R. P. E.

PY - 2012

Y1 - 2012

N2 - <p>Whole-body ultraviolet (UV)A1 (340400 nm) phototherapy was first introduced 30 years ago, but is currently available in the UK in only three dermatology departments. A workshop to discuss UVA1 was held by the British Photodermatology Group in May 2009, the aim of which was to provide an overview of UVA1 phototherapy and its role in practice, and to identify areas in which further studies are required. The conclusions were that UVA1 phototherapy is an effective treatment in several inflammatory skin diseases, including localized scleroderma and atopic eczema (AE); however, deficiencies and limitations exist in the published evidence base. For most diseases, such as AE, other treatments also exist, which are generally more effective than UVA1. However, for some diseases, particularly morphoea, the evidence of efficacy is stronger for UVA1 than for other treatments. Acute adverse effects of UVA1 are minimal. The risk of long-term adverse effects, particularly skin cancer, is unknown. Medium to high doses of UVA1 are needed for efficacy in most situations, but the equipment to deliver such doses is large, expensive and difficult to install. UVA1 is currently underprovided, and the recommendation of the workshop is that more tertiary centres should have access to UVA1 phototherapy in the UK.</p>

AB - <p>Whole-body ultraviolet (UV)A1 (340400 nm) phototherapy was first introduced 30 years ago, but is currently available in the UK in only three dermatology departments. A workshop to discuss UVA1 was held by the British Photodermatology Group in May 2009, the aim of which was to provide an overview of UVA1 phototherapy and its role in practice, and to identify areas in which further studies are required. The conclusions were that UVA1 phototherapy is an effective treatment in several inflammatory skin diseases, including localized scleroderma and atopic eczema (AE); however, deficiencies and limitations exist in the published evidence base. For most diseases, such as AE, other treatments also exist, which are generally more effective than UVA1. However, for some diseases, particularly morphoea, the evidence of efficacy is stronger for UVA1 than for other treatments. Acute adverse effects of UVA1 are minimal. The risk of long-term adverse effects, particularly skin cancer, is unknown. Medium to high doses of UVA1 are needed for efficacy in most situations, but the equipment to deliver such doses is large, expensive and difficult to install. UVA1 is currently underprovided, and the recommendation of the workshop is that more tertiary centres should have access to UVA1 phototherapy in the UK.</p>

KW - Skin Diseases

KW - Ultraviolet Therapy

KW - Humans

KW - Health Services Accessibility

KW - Great Britain

U2 - 10.1111/j.1365-2230.2011.04256.x

DO - 10.1111/j.1365-2230.2011.04256.x

M1 - Article

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

SN - 0307-6938

IS - 3

VL - 37

SP - 219

EP - 226

ER -

Documents

Library & Learning Centre

Contact | Accessibility | Policy